Learn how to design a shareable dashboard that documents midpalatal suture separation, nasal width changes, and dentoalveolar shifts—turning abstract biological change into concrete patient motivation.
TL;DR A MARPE patient dashboard is a visual tracking tool that documents skeletal changes, suture separation, and expansion progress during miniscrew-assisted rapid palatal expansion. Dashboards improve patient engagement, compliance, and clinical decision-making by presenting CBCT-derived measurements and radiographic signs in formats patients understand. Evidence shows structured treatment visualization enhances perceived value and reduces treatment discontinuation.
Patient engagement and compliance remain critical challenges in long-term orthodontic care, particularly in skeletal expansion cases requiring months of incremental activation. A MARPE patient dashboard is a shareable progress-tracking system that visualizes miniscrew-assisted rapid palatal expansion outcomes across multiple time points, helping patients grasp the biological changes occurring beneath the surface. Dr. Mark Radzhabov has developed practical frameworks for documenting these changes in ways that resonate clinically with both adolescents and adult patients. This article outlines the rationale, design principles, and evidence-based metrics for building a dashboard that communicates progress, justifies treatment costs, and strengthens the clinician–patient relationship throughout miniscrew-assisted expansion therapy.
A MARPE patient dashboard is a visual documentation system that tracks skeletal, dentoalveolar, and radiographic changes during miniscrew-assisted rapid palatal expansion, presented in formats that enhance patient comprehension and clinical decision-making. Unlike static radiographs or clinical notes, a dashboard integrates measurements across time points—typically pretreatment (T0), immediate post-expansion (T1), and consolidation phase (T2)—and renders them in charts, overlays, and comparative images that patients can understand intuitively. The dashboard serves dual purposes: clinical and communicative. Clinically, it provides a repository for skeletal landmarks—nasal width, greater palatine foramen position, midpalatal suture separation ratio—that predict expansion success and guide retention duration. Communicatively, it demonstrates to patients and parents why treatment duration extends beyond active expansion, justifying the consolidation phase and reinforcing compliance during long-term retention. Evidence from prospective expansion studies underscores the importance of midpalatal suture separation documentation. A prospective randomized trial reported suture separation frequencies of 90–95% depending on group allocation, with quantifiable differences in nasal width gains between miniscrew-assisted and tooth-borne methods. The dashboard also creates a clinical record that supports case complexity assessment and justifies treatment costs to insurers. When patients visualize their own midpalatal suture widening or nasal expansion on CBCT overlays, perceived value increases, reducing treatment discontinuation and improving financial predictability for the practice.
Adult and late-adolescent patients treated with miniscrew-assisted expansion often struggle with the psychological burden of multi-month activation schedules and invisible skeletal changes. Unlike tooth movement—which patients observe directly in the mirror—skeletal expansion occurs at the midpalatal suture, hidden beneath soft tissue and bone. Without concrete progress markers, patients may perceive treatment as stalled or question the clinical rationale for continued screw activation. Recent research demonstrates that MARPE success varies significantly by age and sex. A clinical study examining 215 subjects found that suture separation success rates were 94.17% in females but only 61.05% in males, with older male patients showing significantly reduced suture separation and basal bone expansion. This age- and sex-dependent variability creates an ethical imperative: clinicians must counsel patients realistically about expected outcomes and document actual separation amounts, not assumed ones. A visual dashboard addressing these nuances—showing individualized suture separation ratios, nasal width gains, and dentoalveolar compensation—transforms a potentially disappointing narrative (“your body isn't responding as expected”) into an evidence-based one (“your expansion pattern reflects normal biology at your age. Here's what we measure”). Dashboards also reduce clinician liability. When treatment outcomes diverge from expectations—insufficient basal bone expansion, asymmetric suture separation, or unexpected dentoalveolar tipping—a documented baseline and serial measurements provide an objective record of biological response, distinguishing appliance performance from patient anatomy.
A clinically robust MARPE patient dashboard integrates measurements across three domains: skeletal, dentoalveolar, and periodontal. Each domain uses landmarks derived from low-dose CBCT imaging, allowing serial comparisons without radiation burden concerns. Skeletal metrics form the foundation. Midpalatal suture separation ratio—measured as the widest separation point divided by the pretreatment midpalatal width—quantifies basal bone expansion and correlates strongly with biological success. Nasal width at the molar region (M-NW) and at the level of the greater palatine foramen (GPF) capture maxillary base widening. These are particularly sensitive to miniscrew-assisted mechanisms, which drive lateral expansion more efficiently than tooth-borne methods. A prospective trial documented significantly greater increases in M-NW and GPF width in miniscrew-assisted groups, demonstrating that skeletal outcomes justify the additional surgical placement burden. Dentoalveolar metrics track compensation patterns. Bilateral first premolar and molar maxillary width (PM-MW, M-MW), measured from buccal root apex to palatal root apex, reveal whether expansion distributes evenly across the arch or concentrates anteriorly. Buccal bone plate thickness (BBPT) and palatal bone plate thickness (PBPT) at multiple tooth levels indicate whether the expansion mechanism stressed supporting bone. Miniscrew-assisted protocols produce significantly less buccal displacement of anchor teeth—a measurable advantage over tooth-borne expansion—making this metric essential for demonstrating clinical superiority to patients paying out-of-pocket. Periodontal metrics document gingival and bone health. Gingival recession at anterior and posterior sites, alveolar crest position, and periodontal ligament space integrity should be tracked at T0, T1, and T2 to ensure expansion did not compromise periodontal support. Including these on the dashboard reassures patients and parents that expansion prioritizes long-term periodontal health.
A patient-facing MARPE dashboard typically combines three visual elements: baseline and follow-up CBCT coronal images with anatomical landmarks annotated, quantitative measurement charts tracking midpalatal suture separation and nasal width over time, and before-and-after intraoral or extraoral photos aligned with skeletal changes. Baseline imaging and landmark annotation: At treatment initiation, obtain a low-dose CBCT and mark key landmarks: anterior and posterior midpalatal suture boundaries, greater palatine foramen, nasal floor, and the widest point of nasal base. Save these annotated images as the reference (T0). Immediately after active expansion (T1) and again after consolidation (T2), repeat imaging and remeasure identical landmarks. Overlay T0 and T1 images side-by-side so patients visually appreciate suture widening. The contrast is often striking and emotionally compelling. Quantitative charting: Create a simple line graph plotting midpalatal suture separation ratio (y-axis) against weeks of treatment (x-axis). Add milestone markers (“screw placement,” “active expansion complete,” “consolidation begins,” “retention begins”) so patients understand the treatment arc. Include a second chart showing expected nasal width gain based on the randomized trial data—this contextualizes the patient's actual gain as “above expected,” “on target,” or “below expected,” anchoring discussion in evidence rather than clinic opinion. Intraoral and extraoral comparison: If nasal width expansion is clinically noticeable, include frontal and basal view extraoral photos at T0 and T2. Patients often report that visible nasal or smile-width changes motivate ongoing retention compliance, even after the miniscrews are removed. Periodontal and dentoalveolar overlay: For adult and older adolescent patients concerned about long-term periodontal health, include a CBCT-derived cross-section at a key dentoalveolar site showing alveolar crest position and gingival contour at T0 and T2. This directly addresses the unspoken patient fear: “Will expansion damage my bone or gums?” Demonstrating maintained or improved periodontal anatomy is powerful reassurance. Dashboards are most effective when printed and reviewed in-person during activation and consolidation appointments. Many clinicians now use tablet-based presentation during these visits, allowing patients to ask questions and engage interactively. Dr. Mark Radzhabov has incorporated dashboard reviews into patient education protocols, noting significant improvements in patient satisfaction scores when visual progress is formally discussed rather than assumed.
MARPE success is profoundly age-dependent, making personalized dashboard messaging essential. Adolescent patients (ages 11–17), particularly females, demonstrate near-universal suture separation (>90%) and robust skeletal gains. For this group, the dashboard should emphasize the biological advantage of timing—“your open midpalatal suture is naturally responsive. This expansion will be permanent.” Chart expected timelines conservatively (8–12 weeks active expansion, 6 months consolidation) to manage expectations and reinforce compliance during the “plateau” phase when visible intraoral changes slow. Young adults (ages 18–30) show variable results. Female patients maintain high separation rates (≥90%), while male patients experience success rates near 70%. A dashboard for young adults should transparently present these sex-based probabilities at the outset, with a clause stating, “We will assess suture response after 4 weeks. If separation is incomplete, we will discuss surgical adjunctive options.” This honest framing prevents patient disappointment and supports informed consent. Older adults (age >30, particularly males) require the most cautious messaging. Suture separation success drops below 65% in males over age 40, and even when suture separation occurs, the amount of basal bone expansion may be modest. For this population, the dashboard should foreground dentoalveolar gains (increased maxillary inter-molar width, corrected posterior crossbite) rather than purely skeletal metrics, as biological expectations differ. Including a detailed cost-benefit analysis—“here's what we'll definitely gain (better occlusion, nasal airway widening). Here's what we'll attempt (basal bone expansion), with success likelihood of 55–70% based on your demographics”—reinforces realistic expectations and justifies the treatment course even if miniscrew-assisted expansion yields mixed skeletal results. The dashboard becomes a tool for case selection and treatment planning, not just outcome communication. Clinicians can show prospective patients their demographic-specific success curves, allowing truly informed choice about whether MARPE, conventional RPE (in younger patients), or orthognathic correction serves them best.
A comprehensive MARPE patient dashboard evolves across five treatment phases, each with distinct documentation priorities. During the pre-treatment phase, include baseline CBCT coronal and sagittal images, pretreatment intraoral photos, and a written consent document explicitly stating expected skeletal expansion metrics (based on age/sex) and consolidation duration. This creates a documented baseline for all future comparisons. During the active expansion phase (typically 4–10 weeks with miniscrew activation 3–4 turns daily or as specified by protocol), update the dashboard every 2 weeks with intraoral photos and screw turn count. At the 4-week checkpoint, obtain a limited periapical radiograph to assess early suture separation. Include this radiograph on the dashboard with a written interpretation (“Suture separation: [yes/no]. Amount: [estimated]”). This early checkpoint is critical for older male patients, as a 4-week radiograph can prognosticate whether continued activation will yield clinically meaningful basal bone expansion or whether surgical assistance should be offered. During the consolidation phase (typically 4–6 weeks, with screw deactivation 3 turns daily, then complete cessation), document weekly intraoral photos and weekly screw position images. Many patients perceive this phase as “nothing is happening”—a dashboard showing the screw position held constant and the dentoalveolar tissues adapting visually around it provides tangible evidence of biological consolidation. Include a written note: “The screw remains in place (locked) while your bone hardens around the expansion. The harder it hardens, the more stable your result.” At the immediate post-expansion phase (T1 imaging, typically week 6–10 after miniscrew placement), conduct CBCT imaging and remeasure all skeletal landmarks. Generate a comparison overlay showing T0 and T1 coronal images side-by-side, with quantitative gain table: midpalatal suture separation ratio, M-NW, M-MW, periodontal metrics. Include a clinical summary statement addressing the patient by name: “[Patient name], your expansion achieved 8.2 mm of nasal widening and a suture separation ratio of 2.4—excellent results for your age group. Your bone is now locked in this new width.” Celebrate successes. Address shortfalls realistically (“Your basal separation is 1.8 mm, which is modest but clinically meaningful for skeletal support of the corrected occlusion”). During the retention phase (miniscrews typically left in situ 4–6 months, then removed. Retention appliance worn 12+ months), the dashboard transitions from skeletal monitoring to dentoalveolar and periodontal stability. Include monthly intraoral photos showing dentoalveolar position and gingival health. At the 3-month consolidation checkpoint, repeat CBCT imaging (T2) and document any relapse in suture position or dentoalveolar widths. A follow-up dashboard comparing T1 and T2 demonstrates skeletal stability (or any relapse) and justifies ongoing retention wear. Each phase should include a simple progress checklist: ✓ Miniscrews stable, no discomfort. ✓ Suture separation confirmed (or pending). ✓ Periodontal health maintained. ✓ Patient compliance on target. This checklist keeps documentation aligned with clinical reality and prevents dashboard content from drifting into purely retrospective, non-actionable records.
Fundamental course covering CBCT patient selection, miniscrew planning, activation protocols, and 60+ clinical cases. Choose the access level that fits your practice.
Essentials of rapid palatal expansion for practicing orthodontists.
Deep-dive into MARPE protocol, diagnostics, and clinical execution.
5-element medical consultation framework for dentists and orthodontists.
Essential skeletal metrics include midpalatal suture separation ratio, nasal width at molar region (M-NW), greater palatine foramen width (GPF), and maxillary inter-molar width (M-MW). Dentoalveolar landmarks include buccal and palatal bone plate thickness (BBPT, PBPT) and first premolar/molar maxillary width (PM-MW, M-MW). Include periodontal metrics: gingival recession and alveolar crest position at T0, T1, and T2.
Update intraoral photos and screw position weekly or bi-weekly. Obtain periapical radiographs at 4-week and 8-week milestones to assess midpalatal suture separation. For patients >30 years old, a 4-week radiographic checkpoint is critical to prognosticate whether continued activation will yield basal bone expansion or warrant surgical consideration.
Acquire CBCT at baseline (T0, pre-treatment), immediately after active expansion completion (T1, typically week 6–10), and at 3-month consolidation checkpoint (T2). This three-time-point protocol is supported by prospective randomized trials and allows reliable landmark measurement with minimal radiation burden.
Present age- and sex-stratified success data transparently. Males >30 years show suture separation success rates of 55–70% compared to >90% in females. Offer a 4-week radiographic checkpoint to assess response. If separation is minimal, discuss orthognathic correction or conventional RPE alternatives. Use the dashboard to emphasize dentoalveolar gains (occlusal correction) even if basal skeletal expansion is modest.
Yes. Include gingival recession, alveolar crest position, and periodontal ligament space at baseline and post-expansion. Many patients fear that skeletal expansion damages bone support. Visualizing maintained or improved periodontal anatomy on CBCT overlays provides reassurance, improves perceived safety, and justifies retention duration to skeptical patients.
Use side-by-side CBCT coronal overlays (T0 vs. T1) showing widened nasal base. Quantify the gain in millimeters and compare to demographic-specific expected values from published prospective trials. For visible gains (>5 mm), include frontal extraoral photos. Simple statement: “Your nasal base widened 7.2 mm, improving airway and smile proportions—results typical for your age.”
Consolidation is typically 4–6 weeks after active screw expansion, during which the screw position is held static and surrounding bone hardens around the new expansion width. Many patients perceive this phase as 'nothing happening.' Dashboard documentation with weekly intraoral photos, locked screw images, and clinical notes (“Your bone is hardening in the expanded position”) demonstrates active biological consolidation and justifies retention protocols.
Document the actual suture separation ratio and basal width gain, then present a honest clinical summary: quantify the skeletal result achieved, explain age/sex-related biological constraints, and refocus the clinical goal on dentoalveolar occlusal correction. Avoid messaging that implies treatment 'failed' if biology prevented full suture opening. Instead, frame the outcome as 'clinically meaningful within your bone response pattern.'
Yes. Include a cost-benefit summary on the dashboard listing documented skeletal gains, dentoalveolar improvements, and periodontal stability alongside treatment duration and miniscrew investment. Provide demographic-specific success data. For insurers, include CBCT evidence of midpalatal suture separation and clinical photographs showing occlusal correction—many insurers cover MARPE when skeletal expansion is documented by imaging.
Standard protocol is 4–6 months post-expansion (miniscrews left in situ), then removal and transition to fixed retention appliances for 12+ months. Dashboard T2 imaging at the 3-month consolidation checkpoint verifies skeletal stability before screw removal. Extend retention if CBCT shows early relapse in suture position or dentoalveolar width.
A well-designed MARPE patient dashboard transforms abstract treatment into tangible, measurable progress—a powerful tool for patient motivation and clinical accountability. By integrating CBCT landmarks, suture separation indices, and dentoalveolar changes into a visual format, you create a shared language that clarifies why expansion takes time and why precision matters. The framework outlined here draws on clinical best practices and recent evidence from prospective expansion studies. To implement a dashboard system in your practice or discuss case-specific protocols, explore Orthodontist Mark's consultation resources or enroll in his advanced MARPE training courses. Dr. Mark Radzhabov stands ready to help you refine your skeletal expansion documentation.